TL;DR
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A MedPage Today neurology roundup published Oct. 27, 2026, highlighted three studies on head shape and Alzheimer’s pathology, prenatal phosphatidylcholine and children’s outcomes, and platelet genetics that may affect aspirin’s relationship to dementia prevention. The findings are research signals, not proof that head shape predicts Alzheimer’s, supplements raise every child’s IQ, or aspirin prevents dementia in specific people.
MedPage Today published a neurology roundup on Oct. 27 covering three research developments involving Alzheimer’s and dementia: a study asking whether head shape may influence Alzheimer’s pathology, a randomized trial of prenatal phosphatidylcholine supplements and children’s outcomes, and an analysis suggesting platelet-related genetic differences could affect aspirin’s potential role in dementia prevention. The brief report highlights findings but does not establish clinical recommendations.
The roundup cites an article in Alzheimer’s & Dementia examining whether head shape can influence Alzheimer’s disease pathology. The supplied report does not provide the study’s methods, results, or the nature and strength of any association. It therefore does not establish that a person’s head shape predicts Alzheimer’s or causes changes in brain pathology.
A randomized trial reported in the American Journal of Obstetrics and Gynecology found that prenatal phosphatidylcholine supplements were associated with fewer social withdrawal problems and higher IQ test performance in offspring through age 4. The trial did not find a reduction in attention problems. The roundup provides no effect sizes, participant numbers, or details about the supplement regimen, limiting what can be concluded from the summary alone.
For aspirin, the roundup says ASPREE trial data suggested platelet-count polygenic scores may influence how aspirin might prevent dementia. The report presents this as a possible difference among subgroups of older adults, not evidence that aspirin should be used to prevent dementia. It does not give the relevant subgroup results, the size of any effect, or whether the finding has been replicated.
Three Findings, No New Advice
Together, the studies touch on risk, early development, and prevention—areas that matter to families and older adults, but where early findings can be easy to overread. The reported choline trial offers a longer-term follow-up of children’s test outcomes, while the aspirin analysis points toward the possibility that treatment effects may vary across people. The head-shape research raises a question about how physical characteristics relate to Alzheimer’s pathology.
For now, the practical importance is in the research questions these reports identify, not in a change to care. The roundup does not show that changing head shape affects Alzheimer’s, that prenatal choline should be routinely taken to raise IQ, or that genetic testing can identify who should take aspirin. None of the three summaries supplies enough detail to support those conclusions or individual medical decisions.
Products Worth Considering
Blueair Signature SP1i Smart Air Purifier
Levoit Vital 100 Air Purifier
Withings BPM Vision Blood Pressure Monitor with Wi-Fi and Bluetooth
As an affiliate, we earn on qualifying purchases.
The Studies Behind the Roundup
The source is a short MedPage Today neurology and neuroscience roundup by deputy managing editor Judy George, published Oct. 27, 2026. It lists research reported across medical journals rather than presenting one new clinical guideline or a single study with full methods and data. The three topics appear alongside other brief research notes, so the supplied material gives only selected findings.
The roundup identifies the prenatal supplement paper as a randomized trial and the aspirin finding as an analysis of ASPREE trial data. It describes the head-shape item as research published in Alzheimer’s & Dementia but does not explain its design. Those distinctions matter: a trial, an analysis of existing trial data, and an unspecified study can answer different questions, and the brief summaries do not allow readers to compare their evidence directly.
“Can head shape influence Alzheimer’s disease pathology?”
— MedPage Today roundup, summarizing the head-shape research
Key Study Details Are Missing
The source material does not include the sample sizes, effect estimates, or full methods for these three reports. For the head-shape study, it is unclear what features were measured, whether the research found an association, and how it accounted for other factors. The roundup’s question alone should not be read as a finding.
For the prenatal trial, the summary does not say how many participants were included, what dose or timing of phosphatidylcholine was used, or how large the reported differences were. Follow-up is described through age 4; the supplied information does not establish whether effects persist later. For aspirin, it is unclear which genetic-score groups showed a possible difference, how large it was, or whether the analysis supports a treatment decision. Independent confirmation and fuller publications would be needed to clarify the findings.
Full Results Will Set the Scope
The next step for readers is to consult the full journal reports for design, participant characteristics, statistical results, and study limitations. Further research would be needed to test whether the head-shape observation replicates, whether childhood outcomes after prenatal supplementation persist, and whether platelet-related genetic scores reliably identify differences in aspirin’s effects on dementia.
Until those details and follow-up evidence are available, the roundup does not change established prevention or prenatal-care guidance. People should not start aspirin or supplements, or make changes to prescribed care, based on these short summaries; questions about individual use should be discussed with a qualified health professional.
Key Questions
Does head shape predict Alzheimer’s disease?
The roundup identifies research asking whether head shape may influence Alzheimer’s pathology, but it does not provide results showing that head shape predicts the disease. The study’s methods and findings are not detailed in the supplied report.
Did prenatal phosphatidylcholine improve children’s IQ?
A randomized trial summary reported higher IQ test performance and fewer social withdrawal problems in offspring through age 4. It did not report lower attention problems, and the roundup gives no effect sizes or supplement regimen.
Should older adults take aspirin to prevent dementia?
No recommendation follows from the roundup. It says an ASPREE data analysis suggested platelet-count genetic scores may influence aspirin’s potential effects, but it does not establish who benefits or whether aspirin prevents dementia.
How strong are these findings?
The summaries are too brief to judge strength fully. They omit key details such as sample sizes and effect estimates, and the head-shape report’s design and results are not described. The findings should be treated as research reports, not settled clinical guidance.
Source: rss
